SEARCH

SEARCH BY CITATION

References

  • Ariazi EA, Ariazi JL, Cordera F, Jordan VC (2006). Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6: 195216.
  • Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S (1998). Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54: 105112.
  • Beral V, Banks E, Reeves G., Appleby P (1999). Use of HRT and the subsequent risk of cancer. J Epidemiol Biostat 4: 191210.
  • Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R et al. (2000). Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 141: 29822994.
  • Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O et al. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753758.
  • Edwards JP, Zhi L, Pooley CL, Tegley CM, West SJ, Wang MW et al. (1998). Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists. J Med Chem 41: 27792785.
  • Francucci CM, Romagni P, Boscaro M (2005). Raloxifene: bone and cardiovascular effects. J Endocrinol Invest 28: 8589.
  • Gaido KW, Leonard LS, Maness SC, Hall JM, McDonnell DP, Saville B et al. (1999). Differential interaction of the methoxychlor metabolite 2,2-bis-(p-hydroxyphenyl)-1,1,1-trichloroethane with estrogen receptors alpha and beta. Endocrinology 140: 57465753.
  • Gao H, Katzenellenbogen JA, Garg R, Hansch C (1999). Comparative QSAR analysis of estrogen receptor ligands. Chem Rev 99: 723744.
  • Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P (2004). Comparison of alamarBlue™ and MTT assays for high through-put screening. Toxicol In Vitro 18: 703710.
  • Harnagea-Theophilus E, Miller MR (1998). Acetaminophen alters estrogenic responses in vitro: stimulation of DNA synthesis in estrogen-responsive human breast cancer cells. Toxicol Sci 46: 3844.
  • Ji Q, Gao J, Wang J, Yang C, Hui X, Yan X et al. (2005). Benzothieno[3,2-b]indole derivatives as potent selective estrogen receptor modulators. Bioorg Med Chem Lett 15: 28912893.
  • Jisa E, Dornstauder E, Ogawa S, Inoue S, Muramatsu M, Jungbauer A (2001). Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene. Biochem Pharmacol 62: 953961.
  • Khan IM, Yaksh TL, Taylor P (1994). Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine. J Pharmacol Exp Ther 270: 159166.
  • Klinge CM, Jernigan SC, Mattngly KA, Risinger KE, Zhang J (2004). Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 33: 387410.
  • Legler J, Van den Brink CE, Brouwer A, Murk AJ, Van der Saag PT, Vethaak AD et al. (1999). Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48: 5566.
  • Ohmichi M, Tasaka K, Kurachi H, Murata Y (2005). Molecular mechanism of action of selective estrogen receptor modulator in target tissues. Endocr J 52: 161167.
  • Raafat AM, Hofseth LJ, Li S, Bennett JM, Haslam SZ (1999). A mouse model to study the effects of hormone replacement therapy on normal mammary gland during menopause: enhanced proliferative response to estrogen in late postmenopausal mice. Endocrinology 140: 25702580.
  • Rosendaal FR, Vessey M, Rumley A, Daly E, Woodward M, Helmerhorst FM et al. (2002). Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis. Br J Haematol 116: 851854.
  • Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA et al. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927937.
  • Shiau SP, Glasebrook A, Hardikar SD, Yang NN, Hershberger CL (1996). Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: a positive selection system. Gene 179: 205210.
  • Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ et al. (1997). Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52: 141164.
  • Shyamala G, Chou YC, Louie SG, Guzman RC, Smith GH, Nandi S (2002). Cellular expression of estrogen and progesterone receptors in mammary glands: regulation by hormones, development and aging. J Steroid Biochem Mol Biol 80: 137148.
  • Siddiqui NI, Rahman S, Mia AR, Shamsuzzaman AK (2005). Evaluation of hormone replacement therapy. Mymensingh Med J 14: 212218.
  • Sporn MB, Dowsett SA, Mershon J, Bryant HU (2004). Role of raloxifene in breast cancer prevention in postmenopausal women: clinical evidence and potential mechanisms of action. Clin Ther 26: 830840.
  • Steffen KA, Carnes M (2000). Hormone replacement therapy in prevention of morbidity and mortality in the older woman: part III: potential adverse effects of hormone replacement therapy. J Am Med Dir Assoc 1: 117121.
  • Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN et al. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295: 27272741.
  • Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Wolmark N (2002). The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial. Clin Breast Cancer 3: 153159.
  • Wang ZQ, Lou YJ (2004). Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur J Pharmacol 504: 147153.
  • Wu B, Gao J, Wang MW (2005). Development of a complex scintillation proximity assay for high-throughput screening of PPARγ modulators. Acta Pharmacol Sin 26: 339344.
  • Yang C, Xu G, Li J, Wu X, Liu B, Yan X et al. (2005). Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo. Bioorg Med Chem Lett 15: 15051507.